Revenue for the quarter increased by 15% to 121 MNOK - the highest ever
recorded. Recurring revenues rose by 12% to 93 MNOK. The EBITDA came in at 27
MNOK, representing a margin of 22%.

CEO Sverre Flatby commented on the quarter:
"The combination of growth and profitability means it's time to revitalise our
ambitious growth plans."

Omda maintains its guidance of NOK 460-485 million in revenue for 2025, with a
full-year EBITDA margin of 23%-27%.

"By the end of 2025, we will have more than doubled our annual revenue since the
IPO. The question now is how quickly we can double it again," Flatby said.


Highlights from the report:

o	Reported revenue increased 15% and reached NOK 121 million, compared to NOK
106 million in Q1-24.
o	EBITDA reported at NOK 27 million, resulting in a 22% margin compared to 14%
in Q1-24.
o	Organic growth stood at 7% in local currency versus Q1-24.
o	Recurring revenue totalled NOK 93 million, up from NOK 83 million in Q1-24,
accounting for 77% of total revenue.
o	Successfully completed acquisitions of Dermicus and Aweria

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 500 customers in 27
countries and employs more than 250 dedicated specialists. Our highly
specialised healthcare solutions empower medical professionals and emergency
responders, enabling them to know more and work smarter. With a focus on
user-centric design, value-driven development and close working relationships
with customers, Omda delivers solutions that enhance patient safety and improve
healthcare outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH